These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects. Zwanzger P; Zavorotnyy M; Gencheva E; Diemer J; Kugel H; Heindel W; Ruland T; Ohrmann P; Arolt V; Domschke K; Pfleiderer B Neuropsychopharmacology; 2013 Aug; 38(9):1648-54. PubMed ID: 23463151 [TBL] [Abstract][Full Text] [Related]
8. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Eser D; Schüle C; Baghai T; Floesser A; Krebs-Brown A; Enunwa M; de la Motte S; Engel R; Kucher K; Rupprecht R Psychopharmacology (Berl); 2007 Jul; 192(4):479-87. PubMed ID: 17318504 [TBL] [Abstract][Full Text] [Related]
10. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers. Eser D; di Michele F; Zwanzger P; Pasini A; Baghai TC; Schüle C; Rupprecht R; Romeo E Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707 [TBL] [Abstract][Full Text] [Related]
11. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136 [TBL] [Abstract][Full Text] [Related]
12. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Koszycki D; Zacharko RM; Le Mellédo JM; Bradwejn J Depress Anxiety; 1998; 8(1):1-7. PubMed ID: 9750972 [TBL] [Abstract][Full Text] [Related]
13. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. Mantovani A; Aly M; Dagan Y; Allart A; Lisanby SH J Affect Disord; 2013 Jan; 144(1-2):153-9. PubMed ID: 22858212 [TBL] [Abstract][Full Text] [Related]
15. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers. Tõru I; Aluoja A; Võhma U; Raag M; Vasar V; Maron E; Shlik J Psychiatry Res; 2010 Jul; 178(2):342-7. PubMed ID: 20471107 [TBL] [Abstract][Full Text] [Related]
16. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder. Kellner M; Yassouridis A; Jahn H; Wiedemann K Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081 [TBL] [Abstract][Full Text] [Related]